Jan Biegus

@marcin_kurzyna Gratulacje! Well deserved!

Top trending papers in Chronic Thromboembolic Pulmonary Hypertension - Poland as a country and European Health Center Otwock, as a single centre in distinguished companionship 😀 Chronic thromboembolic pulmonary hypertension: insights from the 100 most cited papers: a bibliometric perspective jtd.amegroups.org/article/view/1…

Safety and efficacy of early initiation of MRA after an acute decompensated HF event or acute MI with cardiac dysfunction: a meta-analysis of RCTs. see @ESCHeartFailure see: ow.ly/M9eK50YnWW1 #ESCHeartFailure @EJHFEiC @JanBiegus @Ppponikowski #HFA_ESC @hvanspall @ShelleyZieroth @FudimMarat @gcfmd @AlexMebazaa @MarcoMetra @GianluSava

@EJHFEiC @ESC_Journals @GiuseppeGalati_ @AmrAbdin10 @HanCardiomd Thank you for sharing this!

🗞️ #SGLT2i in heart failure. How durable is the decongestive effect? @ESC_Journals @GiuseppeGalati_ @AmrAbdin10 @HanCardiomd bit.ly/3OUfS9k

Which drugs can worsen #HeartFailure? This #EJHF expert consensus highlights some pharmacologic pitfalls clinicians must recognize, for example: 📍NSAIDs: fluid retention
📍Antidiabetics (TZDs, some DPP4i): ⬆️risk of HF hospitalization
📍Non-DHP CCBs: negative inotropy
📍Antifungals (itraconazole, amphotericin B): myocardial toxicity, negative inotropy
📍Neuro/psych drugs (lithium, pramipexole): cause/exacerbate fluid overload
📍Some cancer treatments (e.g. Anthracyclines, HER2 targeted therapies: risk for cardiotoxicity 
Read more🔗 doi.org/10.1002/ejhf.7… @escardio @EJHFEiC @MarcoMetra @jozinetm @AmrAbdin10 @GianluSava #HFrEF

Global burden of heart failure due to cardiovascular diseases, 1990-2021 and predictions to 2035 based on GBD 2021 See at: ow.ly/K6sy50Y5hBX @EJHFEiC @JanBiegus @Ppponikowski #HFA_ESC @hvanspall @ShelleyZieroth @FudimMarat @gcfmd @AlexMebazaa @MarcoMetra @GianluSava

#GDMT implementation after revascularization in #HFrEF #IschaemicCardiomyopathy: 
📍GDMT implementation was associated with lower unadjusted mortality after revascularization
📍The most favorable outcomes were seen with GDMT + CABG 📍GDMT use increased over time but remained suboptimal Read more at @ESCHeartFailure : doi.org/10.1002/ehf2.7… @escardio @MarcoMetra @jozinetm #HeartFailure

#CardioImmunology is reshaping how we understand myo-pericardial diseases🫀 This @ESCHeartFailure article highlights that: 📍Myocardial #inflammation is observed across #myocarditis & #genetic #cardiomyopathy
📍Genetic variants such as #TTN, #DSP are reported in patients with biopsy-proven myocarditis
📍Arrhythmogenic #CMP may present with myocarditis-like inflammatory “hot phases”
📍Immune-related genetic variants are described in recurrent #pericarditis 📍Multimodal approach including imaging (#whyCMR, #ThinkPET), histology #EMB, & #genetictesting is essential More🔗: doi.org/10.1002/ehf2.1… #HeartFailure @escardio @ESC_Journals @MarcoMetra @_antocannata @SilCastelletti @AlbertoAimo90 @ImazioMassimo

📌 Which medications should we avoid in HF patients ⁉️ This position 🗞️ provides a very practical guide in daily clinical practice. 📄 A must-read for clinicians caring for HF pts. 🔗 ow.ly/fwQ250XLsZW @EJHFEiC @AmrAbdin10 @GiuseppeGalati_ @HanCardiomd #EJHF

Why should #ODI events be included in primary outcome in #HF RCTs? - independently assoc’d w ☠️ - inclusion can ⬆️#RCT event rates, ⬇️sample size ⬇️follow up time - produce consistent #RRR, ⬆️#ARR We propose a standard def’n for RCT use in this synthesis eviden.cc/48zIwEp

There is so much to learn from urine 💧in patients with HF! 🔑UACR 🔑urine volume 🔑urine sodium Don’t fall behind and start measuring in your patients NOW! Learn more from this new EJHF Expert Consensus led by @KobayashiMasa13 @JanBiegus onlinelibrary.wiley.com/doi/10.1002/ej…

"Worsening versus advanced #HeartFailure: Management and challenges" - Check out the article in #ESCHeartFailure ow.ly/Y8Wh50XoaB2 @EJHFEiC @JanBiegus @Ppponikowski #HFA_ESC @hvanspall @ShelleyZieroth @FudimMarat @gcfmd @AlexMebazaa @MarcoMetra @GianluSava @thiele_holger

The #HFA_ESC Advanced Heart Failure Course returns in 2026‼️ A unique opportunity to deepen expertise in #HeartTransplantation, mechanical circulatory support, & multidisciplinary #AdvancedHF care🫀, and to engage with global experts in the field 🤝 We look forward to welcoming you to Vienna, Austria 🇦🇹, 12–13 February 2026 Register now 🔗 esc365.escardio.org/event/2071 #HeartFailure @escardio @MajaCikes @kevin_damman @WilfriedMullens @MarcoMetra @jozinetm @h_arfsten @_antocannata @slumberbell @corneliacrm @SotiriaLiori @AmrAbdin10 @GTersalvi @GianluSava

💧 The Chloride Paradigm Shift in Heart Failure From a neglected ion ➜ to a keystone of precision diuretic therapy. 🧠 Hypochloremia drives diuretic resistance, persistent congestion & worse outcomes. 🔄 New therapeutic algorithm integrating Cl⁻ into Mullens' strategy. 🆕 Collaboration🤝 @SENefrologia @secardiologia @IcyfaSemi @ESC_Journals DOI: doi.org/10.1002/ejhf.7…

📢 Simultaneous vaccination against influenza and respiratory syncytial virus in high-risk heart failure patients 👉ttps://doi.org/10.1002/ehf2.15432 #HeartFailure #ESCHeartFailure @EJHFEiC @JanBiegus @Ppponikowski #HFA_ESC @hvanspall @ShelleyZieroth @FudimMarat @gcfmd @AlexMebazaa @MarcoMetra @GianluSava

📢 Early in-hospital treatment of acute heart failure (AHF). Part 2 of the international expert opinion series on AHF management. 👉 ow.ly/mhgp50X7Im1 #HeartFailure #ESCHeartFailure @EJHFEiC @JanBiegus @Ppponikowski #HFA_ESC @hvanspall @ShelleyZieroth @FudimMarat @gcfmd @AlexMebazaa @MarcoMetra @GianluSava

@GianluSava @escardio @_antocannata @jozinetm @HFA_President Wow! Congratulations

3 fantastic days of @escardio #HFA clinical trials course on HF. Fantastic faculty, lot of discussion, and time for enjoy Naples. See you next year! @_antocannata @jozinetm @HFA_President

Acute heart failure care – a consensus series of an international experts' group onlinelibrary.wiley.com/doi/10.1002/ej… #EJHF @ESC_Journals @HanCardiomd @AmrAbdin10 @GiuseppeGalati_

🔥New Scientific Statement from #HFA & #HFAI: SGLT2 inhibitors for the prevention & treatment of #HeartFailure Key recommendations across the HF spectrum:
📍At risk for HF: ⬇️HF events in patients with #T2DM & #CKD, initiate #SGLT2i
📍Post-AMI: ⬇️HFh alone, consider in high-risk patients
📍Symptomatic chronic HF: ⬇️HFh & #CVdeath across LVEF, start early
📍Acute/worsening HF: early benefit on HF events & mild decongestion, initiate inpatient & have 💊 on board before discharge
📍Specific populations (#ATTRCM, #ACHD): observational data suggest safety & potential benefit Read the full statement @ESCHeartFailure ➡️ doi.org/10.1002/ehf2.1… #HFA_ESC #CardioX @escardio @ESC_Journals @MarcoMetra @jozinetm @GMCRosano @GianluSava

🌍Global opportunity alert! The #HFA_ESC Training Grants support #heartfailure specialists to train at top international centers Up to €10,000 for research or clinical training abroad. 📍Application deadline: Sept 30, 2025 📍Under 40 years old✅ 📍HFA member required✅ 📍Early career (MD/PhD)👩‍⚕️👨‍⚕️ 👉Apply now: escardio.org/Education/Care… @escardio @MarcoMetra @jozinetm